Trial Site Detail

 

Drug:
Anlotinib
Trial:
Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

Beijing Cancer Hospital

     
Beijing , Beijing 100142
China

 

Principal Investigator:
Jian Li, MD
Contact:
oncogene@163.com 008613601310849
Activation Status of this Site:
Closed
Notes about this Site:
Beijing Cancer Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.